Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MC3629 |
Synonyms | |
Therapy Description |
MC3629 inhibits EZH2, which results in decreased H3K27 trimethylation, and potentially leads to decreased proliferation and increased apoptosis of tumor cells and reduced tumor growth (PMID: 28978137). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MC3629 | EZH2 inhibitor 20 | MC3629 inhibits EZH2, which results in decreased H3K27 trimethylation, and potentially leads to decreased proliferation and increased apoptosis of tumor cells and reduced tumor growth (PMID: 28978137). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|